Make your own free website on Tripod.com

An evaluation of the association between age and health related quality of life and symptoms functioning in cancer patients.  

C. Quinten, F. Martinelli, J. Maringwa, C. Coens, E. Greimel, H. Flechtner, J. Schmucker-Von Koch, M. Taphoorn, J. Weis, A. Bottomley on behalf of the EORTC

Background

Previous studies have demonstrated the prognostic value of age in cancer survival, with older cancer patients reporting a poorer survival rate than younger patients. However, it is important to understand age-associated factors, such as Health Related Quality of Life (HRQOL) to create a more detailed picture about the health status of cancer patients in different age categories.  The objective of this study was therefore to investigate the influence of age on the HRQOL of cancer patients.  

Methods

Patients from 30 closed European Organisation for Research and Treatment of Cancer (EORTC) Randomized Controlled Trials, covering 11 cancer sites, were included in this retrospective meta-analysis. HRQOL was recorded using the EORTC QLQ-C30. The variable age was dichotomized at 70 years; representative for younger and older cancer patients. A multivariate analysis modelling the binary variable age, corrected for gender, cancer site, disease severity (metastases vs non metastases), World Health Organization (WHO) performance status on 15 HRQOL scales was investigated. 

Results

Baseline HRQOL data were available for 5,388 patients younger than or equal to 70 and 718 patients older than 70. Age was a significant prognostic factor (<.001) with elderly having a poorer survival. Additionally, HRQOL impairment between the two age groups was reported at baseline for global health status (<.001), physical functioning (<.001), role functioning (0.009), cognitive functioning (<.001), financial difficulties (<.001) and for the symptoms fatigue, nausea&vomiting, pain, dyspnea, appetite loss, constipation (all <.001). For the functioning and symptom scales; older people reported a poorer HRQOL compared to younger people. However, interestingly older cancer patients reported a lower financial burden compared to younger people.  

Conclusions

Our meta-analysis indicates that the HRQOL of older cancer patients is affected differently by cancer compared to younger patients. Older people reported had a poorer score in different HRQOL domains. Health care professionals should be aware that the most vulnerable cancer patients are older people and hence our results could provide insights to help provide suitable clinical awareness and care for more senior patients. However, older patients in general reported that the financial burden of this disease was of a limited impact compared to younger patients. This could be important for supportive care services when treating less senior patients.